Clinical Trial Update: Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA) [Phase 3]

View source ↗

Summary

A Phase 3 randomized, placebo-controlled trial evaluating budesonide MMX 9 mg in ulcerative colitis patients on 5-ASA; study completed with results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Budesonide-MMX 9 mg (budesonide)

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2019-09-06